Published in PLoS Med on October 05, 2010
Real-time numerical forecast of global epidemic spreading: case study of 2009 A/H1N1pdm. BMC Med (2012) 2.13
Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1. Biosecur Bioterror (2011) 1.75
Chinese social media reaction to the MERS-CoV and avian influenza A(H7N9) outbreaks. Infect Dis Poverty (2013) 1.17
Immunosignatures can predict vaccine efficacy. Proc Natl Acad Sci U S A (2013) 0.93
Excess mortality impact of two epidemics of pandemic influenza A(H1N1pdm09) virus in Hong Kong. Influenza Other Respir Viruses (2013) 0.89
Influenza virus vaccines: lessons from the 2009 H1N1 pandemic. Curr Opin Virol (2011) 0.87
The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong. Influenza Other Respir Viruses (2012) 0.86
Determinants of 2009 A/H1N1 influenza vaccination among pregnant women in Hong Kong. Matern Child Health J (2013) 0.83
Likely effectiveness of pharmaceutical and non-pharmaceutical interventions for mitigating influenza virus transmission in Mongolia. Bull World Health Organ (2012) 0.83
Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia. Influenza Other Respir Viruses (2013) 0.82
Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control. PLoS One (2015) 0.79
Adaptive Mutations That Occurred during Circulation in Humans of H1N1 Influenza Virus in the 2009 Pandemic Enhance Virulence in Mice. J Virol (2015) 0.78
Evolution of 2009 H1N1 influenza viruses during the pandemic correlates with increased viral pathogenicity and transmissibility in the ferret model. Sci Rep (2016) 0.77
Publication delay of randomized trials on 2009 influenza A (H1N1) vaccination. PLoS One (2011) 0.76
Academics and competing interests in H1N1 influenza media reporting. J Epidemiol Community Health (2013) 0.76
Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity. BMC Infect Dis (2011) 0.76
Performance of rapid influenza diagnostic tests (QuickVue) for influenza A and B Infection in India. Indian J Med Microbiol (2015) 0.75
Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context. BMC Infect Dis (2016) 0.75
Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1. BMC Infect Dis (2017) 0.75
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med (2009) 16.13
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med (2009) 15.02
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet (2010) 12.43
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90
Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med (2009) 8.99
Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA (2009) 7.61
Influenza pandemics of the 20th century. Emerg Infect Dis (2006) 7.19
Closure of schools during an influenza pandemic. Lancet Infect Dis (2009) 6.68
Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65
Conflicts of interest. WHO and the pandemic flu "conspiracies". BMJ (2010) 6.64
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med (2010) 5.90
Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med (2009) 5.68
Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis (2009) 5.56
Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ (2009) 4.99
Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med (2009) 4.70
Preparing for the next pandemic. N Engl J Med (2005) 4.65
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85
Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ (2010) 3.43
School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerg Infect Dis (2010) 3.42
2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA (2010) 3.05
Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. J Infect Dis (2010) 2.85
Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons. PLoS Curr (2010) 2.77
Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ (2005) 2.72
Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases. Emerg Infect Dis (2005) 2.30
Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC Infect Dis (2010) 2.05
Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill (2010) 1.95
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med (2010) 1.83
Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010. MMWR Morb Mortal Wkly Rep (2010) 1.81
Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan. PLoS Curr (2009) 1.70
Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health (2010) 1.54
What Mexico taught the world about pandemic influenza preparedness and community mitigation strategies. JAMA (2009) 1.36
Influenza (H1N1) 2009 outbreak and school closure, Osaka Prefecture, Japan. Emerg Infect Dis (2009) 1.33
Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis. PLoS Med (2010) 1.33
Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). N Engl J Med (2009) 1.29
Europe's initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices. Euro Surveill (2009) 1.16
Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. MMWR Morb Mortal Wkly Rep (2010) 1.15
A new decade, a new seasonal influenza: the Council of the European Union Recommendation on seasonal influenza vaccination. Euro Surveill (2010) 1.08
How well are we managing the influenza A/H1N1 pandemic in the UK? BMJ (2009) 1.01
Estimates of the transmissibility of the 1968 (Hong Kong) influenza pandemic: evidence of increased transmissibility between successive waves. Am J Epidemiol (2009) 0.98
Early observational research and registries during the 2009-2010 influenza A pandemic. Crit Care Med (2010) 0.85
The truth about Tamiflu? Neuraminidase inhibitors in pandemic A/H1N1 flu. BMJ (2010) 0.77
Avian influenza A (H5N1) infection in humans. N Engl J Med (2005) 12.95
Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis (2006) 6.85
Closure of schools during an influenza pandemic. Lancet Infect Dis (2009) 6.68
Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis (2006) 4.34
Consent, confidentiality, and the threat to public health surveillance. BMJ (2002) 3.96
Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine (2011) 2.24
Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet (2004) 1.77
Comment on "Seroevidence for H5N1 influenza infections in humans: meta-analysis". Science (2012) 1.58
The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy. Influenza Other Respir Viruses (2012) 1.20
Seroprevalence to influenza A(H1N1) 2009 virus--where are we? Clin Vaccine Immunol (2011) 1.11
The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence. Influenza Other Respir Viruses (2011) 1.05
Proposed new International Health Regulations. BMJ (2005) 0.98
Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting. Influenza Other Respir Viruses (2012) 0.93
The importance of influenza prevention for public health. Hum Vaccin Immunother (2012) 0.89
School closures during the 2009 influenza pandemic: national and local experiences. BMC Infect Dis (2014) 0.89
Seasonal and pandemic influenza vaccines for the elderly and other risk groups: a review of available data. Pol Arch Med Wewn (2009) 0.87
The epidemiology of progressive intellectual and neurological deterioration in childhood. Arch Dis Child (2009) 0.85
Europe makes progress in preparing for influenza pandemic, but further work needed. Euro Surveill (2005) 0.79
The truth about Tamiflu? Neuraminidase inhibitors in pandemic A/H1N1 flu. BMJ (2010) 0.77
Modelling the risk-benefit impact of H1N1 influenza vaccines. Eur J Public Health (2013) 0.75
Social justice is a global issue: ethical pandemic planning. Hastings Cent Rep (2008) 0.75
A/H5N1 in the European Union: current levels of risk to humans, and responding to human cases and outbreaks. Euro Surveill (2006) 0.75
H5N1 avian influenza: update on the global situation. Euro Surveill (2005) 0.75
Letter to the editor: Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season. Euro Surveill (2007) 0.75
World Health Assembly approves new International Health Regulations. Euro Surveill (2005) 0.75